欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0135/001
药品名称
Milbemax tablets for small dogs and puppies
活性成分
milbemycin A<3>-oxim 2.5 mg
praziquantel 25.0 mg
剂型
Tablet
上市许可持有人
Novartis A.H.
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Sweden (SE)
Norway (NO)
Finland (FI)
Poland (PL)
Hungary (HU)
Cyprus (CY)
Czechia (CZ)
Slovakia (SK)
Slovenia (SI)
许可日期
2003/04/17
最近更新日期
2023/09/20
药物ATC编码
QP54AB51 milbemycin oxime, combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full Dossier (art.5)
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
Final SmPC _ Milbemax puppy
Date of last change:2024/09/06
Final Product Information
|
Milbemax_Chewable_SmallDog_en_MRP_QRD_clean_Final
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase